The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: A national cross-sectional survey

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Iwase, Satoru ^a   Yamaguchi, Takuhiro ^b   Miyaji, Tempei ^c   Terawaki, Kiyoshi ^d   Inui, Akio ^e   Uezono, Yasuhito ^d  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Kampo; Kampo medicine; Palliative care; Survey; Symptom management

Indexed keywords

KAMPO;

ABDOMINAL DISCOMFORT; ADJUSTMENT DISORDER; ADULT; ANASARCA; ANEMIA; ANOREXIA; ARTICLE; CANCER FATIGUE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CONSTIPATION; DEPRESSION; DIARRHEA; DRUG ANALYSIS; DRUG DOSAGE FORM; DRUG EFFICACY; DYSPHAGIA; DYSPNEA; FEMALE; HEALTH SURVEY; HERBAL MEDICINE; HUMAN; HYPESTHESIA; ILEUS; INSOMNIA; JAPAN; LEG CRAMP; MALE; MUSCLE CRAMP; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NOCTURIA; PARESTHESIA; PRESCRIPTION; QUESTIONNAIRE; SLEEP DISORDER; STOMATITIS; SYMPTOMATOLOGY; TASTE DISORDER; XEROSTOMIA;

EID: 84869151091     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-222     Document Type: Article

References (31)

1. Yu F, Takahashi T, Moriya J, Kawaura K, Yamakawa J, Kusaka K, Itoh T, Morimoto S, Yamaguchi N, Kanda T. Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res 2006, 34:231-239.
2. Terasawa K. Evidence-based reconstruction of Kampo medicine: Part I -Is Kampo CAM?. Evid Based Complement Altern Med 2004, 1:11-16.
3. Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, Imazu Y, Reissenweber H, Witt CM. Traditional Japanese Kampo medicine: Clinical research between modernity and traditional medicine-the state of research and methodological suggestions for the future. Evid Based Complement Altern Med 2011, 2011:1-19.
4. Nishimura K, Plotnikoff GA, Watanabe K. Kampo medicine as an integrative medicine in Japan. Jpn Med Assoc J 2009, 52(3):147-149.
5. Watanabe K. General Practitioner Should Use Kampo Medicine http://mric.tanaka.md/2008/10/22/_vol_148.html.
6. Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med 2002, 10(2):84-93. 10.1054/ctim.2002.0519, 12481956.
7. Hori S, Mihaylov I, Vasconcelos JC, McCoubrie M. Patterns of complementary and alternative medicine use amongst outpatients in Tokyo. Japan. BMC Complement Altern Med 2008, 8:14.
8. Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005, 23(12):2645-2654.
9. Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract 2012, 66:915-916. 10.1111/j.1742-1241.2012.03002.x, 22994325.
10. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AMA, Platin N, Kearney N, Patiraki E. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005, 16:655-663. 10.1093/annonc/mdi110, 15699021.
11. Arai I. The current situation of the Japanese medical plants industry and its significance for the pharmaceutical industry http://hdais.coa.gov.tw/htmlarea_file/web_articles/hdais/1354/980108_1.pdf.
12. Miyoshi A, Yachi A, Masamune O, Ishikawa M, Fukutomi H, Niwa H, Matsuo Y, Mori H, Harasawa S. Clinical evaluation of Rikkunshito (TJ-43 TSUMURA & Co.) for indeterminate digestive complaints including chronic gastritis, etc. Multi-institutional study with reference drug of Cisapride. Prog Med 1991, 11:1605-3. in Japanese.
13. Tatsuta M, Iishi H. Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993, 7:459-462.
14. Harasawa S, Miyoshi A, Miwa T, Masamune O, Matsuo Y, Nakazawa S, Suyama T, Hayakawa A, Nakajima M. Clinical test of ataxia-type upper abdominal disorder (dysmotility-like dyspepsia) after multiple facilities cooperated marketing of Kampo medicine TJ-43 Rikkunnshitou. Examination by double blind experiment group comparison. J Clin Exp Med (IGAKKU NO AYUMI) 1998, 187:207-229. in Japanese.
15. Gochi A, Hirose S, Sato K, Hiramatsu S, Asakura A, Tokuoka H, Matsuno T, Kamikawa Y, Orita K. The Effect of Hange-shashin-to and Rikkunshi-to against the digestive symptoms after gastrectomy. Jpn J Gastroenterol Surg 1995, 28:961-965. in Japanese.
16. Nakajima O, En S. Comparative analysis of the Kampo medicine Rikkunshito's clinical efficacy on patients with functional dyspepsia. Jpn J Med Pharmacol Sci 2008, 59:235-240. in Japanese.
17. Endo G. Analysis of the Rikkunshito efficacy on patients with functional dyspepsia. Jpn J Med Pharmacol Sci 2008, 60:547-552. in Japanese.
18. Oka T, Tamagawa Y, Hayashida S, Kaneda Y, Kodama N, Tsuji S. Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med 2007, 1:21. 10.1186/1751-0759-1-21, 2204024, 18001480.
19. Okabe T, Tsutani K. Evidence Reports of Kampo Treatment (EKAT) Appendix 2011 http://www.jsom.or.jp/medical/ebm/ere/pdf/EKATE_Appendix_2011.pdf.
20. Uezono Y, Miyano K, Sudo Y, Suzuki M, Shiraishi S, Terawaki K. A review of traditional japanese medicines and their potential mechanism of action. Curr Pharm Des 2012, 18:1-15. In Press.
21. Cancer Control Information Center, National Cancer Center Cancer Information Service http://ganjoho.jp/public/index.html, Cancer Control Information Center, National Cancer Center.
22. Kautio AL, Haanpää M, Kautiainen H, Kalso E, Saarto T. Burden of chemotherapy-induced neuropathy-a cross-sectional study. Support Care Cancer 2010, 19:1991-1996.
23. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002, 94(2):528-538. 10.1002/cncr.10245, 11900238.
24. Breitbart W, Bruera E, Chochinov H, Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage 1995, 10:131-141. 10.1016/0885-3924(94)00075-V, 7730685.
25. Massie MJ, Holland JC, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983, 140:1048-1050.
26. Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED. Occurrence, causes and outcomes of delirium in patients with advanced cancer. Arch Intern Med 2000, 160:786-794. 10.1001/archinte.160.6.786, 10737278.
27. Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 2005, 9:84-91.
28. Tsumura & Co Product Information http://www.tsumura.co.jp/password/m_square/products/ichiran/ (in Japanese), Tsumura & Co.
29. Arita M. Crude Drug Lsit http://metabolomics.jp/wiki/Persist:CrudeDrugList.
30. The Japanese pharmacopeia fifteenth edition http://jpdb.nihs.go.jp/jp15/(in Japanese).
31. A tolerability and efficacy study of TU-100 for the treatment of postoperative ileus http://clinicaltrials.gov/ct2/show/NCT00266461?term=Daikenchuto+%28TU-100%29&rank=3.